SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Corxel US Advances Portfolio of Oral Drug Candidates

Amanat says Corxel US is advancing oral drug candidates designed to address limitations of existing injectable and oral obesity therapies.

AMAN

Related stories